Carolinas Wealth Consulting’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-157	Closed	-$42.4K	–	35
2025 Q1	$42.4K	Buy	157 +8	+5%	+$2.16K	0.01%	374
2024 Q4	$35.1K	Sell	149 -10	-6%	-$2.35K	0.01%	406
2024 Q3	$43.7K	Buy	+159	New	+$43.7K	0.01%	384